Overview
FLNC-related distal myopathy, also known as FLNC-related handgrip and calf weakness-distal myopathy or Filaminopathy type C, is a rare inherited muscle disease caused by changes (mutations) in the FLNC gene. This gene provides instructions for making a protein called Filamin C, which helps keep muscle fibers strong and properly organized. When this protein does not work correctly, muscle cells gradually break down over time. The disease mainly affects the muscles farthest from the center of the body — particularly the hands and lower legs (calves). People with this condition often notice that gripping objects becomes harder and that their lower legs feel weak or tire easily. Some people also develop problems with their heart muscle (cardiomyopathy) or experience irregular heartbeats, which makes regular heart monitoring very important. Symptoms usually begin in adulthood, often between the ages of 40 and 60, though this can vary. The condition tends to progress slowly over many years. There is currently no cure, but physical therapy, assistive devices, and careful heart monitoring can help people manage symptoms and maintain quality of life. Because this disease is so rare, it is often misdiagnosed or diagnosed late, making genetic testing a key step toward getting the right care.
Also known as:
Key symptoms:
Weakness in the hands, making it hard to grip or hold objectsWeakness in the lower legs and calves, causing difficulty walking or climbing stairsMuscle wasting (shrinking) in the hands and lower legsFoot drop — difficulty lifting the front part of the foot when walkingFatigue in the arms and legs with everyday activitiesIrregular heartbeat (arrhythmia)Enlarged or weakened heart muscle (cardiomyopathy)Difficulty running or keeping up with physical activityTripping or stumbling more than usualMild muscle pain or cramping in affected areas
Clinical phenotype terms (22)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for FLNC-related handgrip and calf weakness-distal myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for FLNC-related handgrip and calf weakness-distal myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for FLNC-related handgrip and calf weakness-distal myopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to FLNC-related handgrip and calf weakness-distal myopathy.
Community
No community posts yet. Be the first to share your experience with FLNC-related handgrip and calf weakness-distal myopathy.
Start the conversation →Latest news about FLNC-related handgrip and calf weakness-distal myopathy
No recent news articles for FLNC-related handgrip and calf weakness-distal myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What genetic testing do you recommend to confirm my diagnosis, and should my family members be tested too?,How often should I have my heart checked, and what specific heart tests do I need?,What physical therapy or exercise program is safe and helpful for my type of muscle weakness?,Are there any clinical trials or research studies I might be eligible to join?,What signs or symptoms should prompt me to seek emergency care right away?,How quickly do you expect my symptoms to progress, and what milestones should I watch for?,Are there any assistive devices or home modifications you recommend to keep me safe and independent?
Common questions about FLNC-related handgrip and calf weakness-distal myopathy
What is FLNC-related handgrip and calf weakness-distal myopathy?
FLNC-related distal myopathy, also known as FLNC-related handgrip and calf weakness-distal myopathy or Filaminopathy type C, is a rare inherited muscle disease caused by changes (mutations) in the FLNC gene. This gene provides instructions for making a protein called Filamin C, which helps keep muscle fibers strong and properly organized. When this protein does not work correctly, muscle cells gradually break down over time. The disease mainly affects the muscles farthest from the center of the body — particularly the hands and lower legs (calves). People with this condition often notice that
How is FLNC-related handgrip and calf weakness-distal myopathy inherited?
FLNC-related handgrip and calf weakness-distal myopathy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does FLNC-related handgrip and calf weakness-distal myopathy typically begin?
Typical onset of FLNC-related handgrip and calf weakness-distal myopathy is adult. Age of onset can vary across affected individuals.